Jonathan Schimmel
Professional Overview
Jonathan Schimmel is a seasoned executive with extensive experience in the life sciences and biotechnology industries. As the Chief Executive Officer of S2 Genomics and a Partner at Macatawa Capital, LP, he leverages his deep expertise in global support, sales operations, and strategic business development to drive innovation and growth.
Experience Summary
Current Roles
Chief Executive Officer, S2 Genomics (2023-05-01 to Present)
As the CEO of S2 Genomics, Jonathan is responsible for leading the company's strategic vision, operational execution, and product development. He is focused on expanding the company's market reach and delivering cutting-edge genomic solutions to customers worldwide.
Partner, Macatawa Capital, LP (2022-06-01 to Present)
In his role as a Partner at Macatawa Capital, LP, Jonathan provides strategic guidance and investment expertise to support the firm's portfolio companies in the life sciences and biotechnology sectors.
Member, Life Science Angels (2015-02-01 to Present)
Jonathan has been an active member of Life Science Angels, a prominent angel investment group, for over seven years. In this capacity, he evaluates investment opportunities and provides mentorship to early-stage companies in the life sciences industry.
Career Progression
Vice President, Global Support and Sales Operations, 10X Genomics (2016-03-01 to 2022-05-01)
During his tenure at 10X Genomics, Jonathan was responsible for leading the company's global support and sales operations, playing a pivotal role in the organization's rapid growth and market expansion.
President, SEEGENE TECHNOLOGIES INC. (2015-04-01 to 2016-03-01)
Prior to joining 10X Genomics, Jonathan served as the President of SEEGENE TECHNOLOGIES INC., where he spearheaded the company's business development and strategic partnerships.
Vice President and General Manager, Bio-Rad Laboratories (2012-05-01 to 2014-11-01)
Earlier in his career, Jonathan held various leadership roles at Bio-Rad Laboratories, including Vice President and General Manager, as well as Manager of Group Marketing and Customer Operations.
Academic Background
Jonathan holds a Bachelor of Science degree in Biochemistry from the University of California, San Diego.
Areas of Expertise
- Life sciences and biotechnology industry expertise
- Global support and sales operations management
- Strategic business development and partnership building
- Venture capital and angel investing
- Product development and innovation
Professional Impact
Throughout his career, Jonathan has demonstrated a track record of driving growth, innovation, and operational excellence in the life sciences and biotechnology sectors. His strategic leadership, technical expertise, and industry insights have been instrumental in the success of the organizations he has been a part of, including 10X Genomics and Bio-Rad Laboratories.
Conclusion
With his extensive experience, proven leadership skills, and deep industry knowledge, Jonathan Schimmel is well-positioned to continue driving transformative change in the life sciences and biotechnology industries. As the CEO of S2 Genomics and a Partner at Macatawa Capital, LP, he is focused on leveraging his expertise to unlock new opportunities, foster innovation, and create sustainable value for his companies and investors.
